Parsley

Parsley (Petroselinum crispum): A Comprehensive Reference

1. Identity, Botanical Classification, and Natural Source

Petroselinum crispum (Mill.) Fuss, belonging to the family Apiaceae (formerly Umbelliferae), is popularly known as parsley — a ubiquitous aromatic herb used for culinary and medicinal purposes worldwide. It is a species of Petroselinum native to the Mediterranean region, specifically southern Italy, Algeria, and Tunisia, and has been widely cultivated as an herb, a spice, and a vegetable.

Parsley is a biennial aromatic plant characterized by an unbranched root, pinnately divided leaves, umbels, and a schizocarp (the characteristic split fruit of the Apiaceae family). It grows as a biennial herb up to 80 cm in length, hairless, with thin stems and triangular outline leaves two to three times pinnate; the flowers are grouped in umbels of 8–20 rays and are yellowish-green, while the fruits are subglobose or ovoid, aromatic, with five equal ribs.

Three principal cultivar groups are commonly recognized:

• Curly-leaf (P. crispum var. crispum) — the most widely recognized garnish form, with tightly curled, compact leaves.
• Flat-leaf / Italian (P. crispum var. neapolitanum) — considered more flavorful and hardier.
• Hamburg or turnip-rooted (P. crispum var. tuberosum) — grown primarily for its enlarged, edible root.

The parts used medicinally and commercially include the entire plant: leaves, fruits (commonly called "seeds"), and roots. It is native to the Mediterranean region but now cultivated worldwide. Parsley seed oil and herb oil are obtained from the above-ground plant parts by steam distillation, while dried leaf flakes are sold commercially as a culinary herb.

The ancient Greek word for parsley was selinon. The name petroselinum, from which "parsley" is derived, is said to have been assigned by Dioscorides, broadly meaning "rock celery" in Greek.

2. Traditional and Historical Use

Ancient Mediterranean Civilizations

The Ebers Papyrus, an ancient Egyptian medical document from circa 1,550 BC, mentions the use of parsley for its therapeutic properties, particularly for its stimulant and carminative effects. Ancient Greeks and Romans used parsley not only as a culinary herb but also for its medicinal benefits, and it has been used in traditional medicine for its diverse health effects.

Ancient Greeks and Romans prescribed it to treat urinary tract infections and kidney stones due to its diuretic properties, which were believed to help flush out toxins and prevent the formation of kidney stones. Dioscorides, in his seminal work De Materia Medica, noted the use of parsley for its diuretic properties, alongside other medicinal plants.

The Romans and the Greeks used parsley as a medicine. Pliny the Elder (23–79 CE), in Chapter 20 of his book The Natural History, describes using a decoction of parsley seeds for kidney troubles and ulcers in the mouth.

In ancient times parsley was used in medicinal concoctions as cure-alls, general tonics, poison antidotes, antirheumatics, and formulations to relieve kidney and bladder stones.

Roman Culinary and Ritual Use

The Romans valued parsley for its medicinal and culinary uses — they used parsley to freshen breath, to treat digestive disorders, to stimulate menstruation, and to prevent intoxication. The ancient Romans would wear garlands of parsley on their heads during feasts to ward off the possibility of intoxication. Parsley spread to other parts of the world through trade and conquest; it was introduced to Britain by the Romans and to Germany by Charlemagne.

Greek Mythology and Symbolism

The ancient Greeks associated parsley with death, as it was supposed to have sprung from the blood of Archemorus, whose name meant "Forerunner of Death." Victors at funeral games — athletic contests held in honor of a recently deceased person — were crowned with parsley, and the saying "to be in need of parsley" was the Greek way of saying that someone was terribly ill and not expected to survive.

Islamic, Moroccan, and Mediterranean Folk Medicine

In Morocco, parsley is mostly used as an elixir to treat arterial hypertension, diabetes, cardiac and renal diseases. In Iran, the seeds are used for various pharmacological effects including antimicrobial action, kidney stones, and digestive disorders; in Turkey, the leaves are used to treat hypertension and diabetes; in Spain, the leaves are used to treat hypertension, diabetes, prostatitis, and anemia; and in Serbia, the leaves are used to treat urinary tract diseases and infections.

Traditional Chinese and Ayurvedic Use

In traditional Chinese medicine, parsley was utilized to treat hypertension and improve digestive health, while Ayurvedic practitioners recommended it for its anti-inflammatory and detoxifying effects.

European Herbal Traditions

In modern herbal medicine, parsley is more popular in Europe than in the USA. Preparations from leaves, roots, and seeds are used for indigestion, gallstones, kidney stones, urinary infections, jaundice, coughs, and asthma; seeds are prescribed for treatment of gout, rheumatism, and arthritis. Parsley oil has been used to regulate menstrual flow in the treatment of amenorrhea and dysmenorrhea; bruised leaves have been applied externally to treat insect bites, lice, skin parasites, and contusions; and parsley tea was used to treat dysentery and gallstones.

Germany's Commission E recognizes the use of parsley leaf or root to relieve irritation of the urinary tract (such as may occur in bladder infections) and to aid in conditions of the urinary system — one of the few formal regulatory recognitions in Western herbal medicine.

3. Key Constituents and Active Compounds

Essential Oils

Parsley contains essential oil in all parts of the plant, with phenylpropane and terpene compounds as the main components. Terpenes and phenylpropanoids are abundant in the oil extracted from parsley seeds, fruits, roots, and leaves; myristicin and apiol, both belonging to the phenylpropanoid class and showing antioxidant activities, are the main components of parsley essential oil. So-called "German" parsley oil contains about 60–80% apiol, whereas "French" parsley oil contains less apiol but more (50–60%) myristicin.

The plant yields no more than 0.06% volatile oil in its aerial parts, while the seed contains 3.5%.

Other notable volatile terpene compounds identified in parsley essential oil include: β-phellandrene, 1,3,8-p-menthatriene, β-pinene, terpinolene, oxypeucedanin, and falcarinol.

Flavonoids

Phenolic compounds and flavonoids — particularly apigenin, apiin, and 6″-acetylapiin — are among the key active compounds identified in Petroselinum crispum. Dried parsley has a particularly high level of apigenin that far exceeds any other vegetables or herbs. Seven phenolic compounds have been identified across cultivar types, including apigenin and kaempferol derivatives; apigenin-O-pentoside-O-hexoside was identified as the major compound in all tested parsley types and is primarily responsible for its antioxidant activity.

Parsley also contains the estrogenic flavone glycosides 6′-acetylapiin and petroside, as well as flavonoids such as apigenin and cosmosiin. Additional flavonoids present include luteolin and quercetin. Luteolin and quercetin contribute to reducing inflammation and protecting against oxidative damage.

Coumarins and Furanocoumarins

Parsley's main constituents include coumarins, furanocoumarins (notably bergapten and imperatorin), ascorbic acid, carotenoids, flavonoids, apiole, various terpenoid compounds, phenylpropanoids, phthalides, and tocopherol. Parsley contains psoralen and related compounds (ficusin, bergapten, majudin, heraclin) that can induce photosensitivity; the plant also contains several antimicrobial furocoumarins including psoralen, 8-methoxypsoralen, 5-methoxypsoralen, oxypeucedanin, and isopimpinellin.

Vitamins and Minerals

Parsley cultivars are known for high vitamin contents, including pantothenic acid (B5), nicotinamide (B3), riboflavin (B2), ascorbic acid (C), thiamine (B1), pyridoxine (B6), beta-carotene (pro-vitamin A), folic acid (B9), alpha-tocopherol (E), and minerals, essential oils, and various polyphenol compounds, mainly flavonoids. Parsley has a high carotenoid content (25.7 mg per 100 g of the edible portion).

Polyacetylenes and Other Constituents

Parsley is rich in flavonoids and other polyphenolic compounds, and also contains furanocoumarins, carotenoids, and polyacetylenes; its leaves are a source of vitamins and minerals. The polyacetylene falcarinol has been specifically identified as a notable constituent.

Chemical Variability

The chemical composition of parsley is highly variable and depends on several factors, such as growing conditions, different cultivars and chemotypes, geographic regions, and the plant organ. The chemical composition differs not only in different parts and varieties of the plant but also in different samples of the same parts of one variety.

4. Mechanisms of Action

Diuretic Mechanism

The diuretic effects of parsley are primarily attributed to the inhibition of the Na⁺/K⁺-ATPase enzyme in the renal cortex and medulla. According to research by Kreydiyyeh and Usta (2002), the mechanism of action of parsley's diuretic effect appears to be mediated through inhibition of the Na⁺–K⁺ pump, which leads to a decrease in Na⁺ and K⁺ reabsorption, leading to an osmotic water flow into the lumen and thus diuresis. Furthermore, compounds such as myristicin and apiol present in parsley enhance this diuretic effect by promoting the excretion of excess salts and water from the body.

Antioxidant Mechanisms

Recent studies have identified apigenin-O-pentoside-O-hexoside as a major compound in parsley, significantly contributing to its antioxidant activity; apigenin also demonstrates antiproliferative activity against A375 human melanoma cells by inducing caspase-3 activity and triggering apoptotic events, and has significant radical scavenger capacity, iron chelation potential, and lipoxygenase inhibition activity.

Anti-inflammatory Mechanisms

Anti-inflammatory properties of flavonoids such as apigenin result from mechanisms including inhibiting the cell cycle, diminishing oxidative stress, improving detoxification enzymes, inducing apoptosis, and stimulating the immune system. Myristicin has demonstrated various pharmacological activities, such as anti-inflammatory, analgesic, and neuroprotective effects.

Antiplatelet Mechanisms

A fraction of aglycone flavonoids from parsley, among which apigenin and kaempferol were identified, showed in vitro inhibition of thrombin, ADP, and collagen-induced platelet aggregation, with IC50 values ranging from 0.08 to 0.28 mg/mL; flavonoids, especially apigenin, appear to have an important contribution to parsley's in vitro antiaggregant effects.

CYP Enzyme Inhibition

Apiole behaves as a mixed-type inhibitor of bacterial human recombinant CYP1A1; both apiole and parsley ethanolic extract interfere with the mutagenicity of the promutagen MeIQx metabolized by the CYP1A subfamily. Consuming apiole in conjunction with pharmaceuticals metabolized by the CYP1A subfamily may result in herb-drug interactions.

Antimicrobial Mechanisms

Apiol, traditionally used as a diuretic, also exhibits antimicrobial properties, making parsley potentially effective in addressing urinary tract infections. Parsley essential oil has shown potential in antioxidant and antimicrobial activities.

5. Scientific Evidence by Area of Use

5.1 Diuretic Activity

A key study published in the Journal of Ethnopharmacology (2002) provided substantial evidence for the advocated diuretic effect of parsley in folk medicine. Rats offered an aqueous parsley seed extract to drink eliminated a significantly larger volume of urine per 24 hours compared to when they drank water; these findings were supported by results of other experiments using an in situ kidney perfusion technique, which also demonstrated a significant increase in urine flow rate with parsley seed extract.

Human data, however, are very limited. A small clinical study in healthy volunteers (N=20) evaluating the effects of parsley tea on urinary composition and urinary stone risk factors showed no effect on urinary indices measurements, including urine volume, pH, sodium, potassium, chloride, urea, creatinine, phosphorus, magnesium, uric acid, cystine, or citric acid content.

In vitro and animal studies have reported the diuretic effect and proposed mechanisms for the use of parsley as a diuretic; however, none of the studies have been conducted to definitively investigate the diuretic effect of parsley in humans at a clinical trial level. A clinical trial registered on ClinicalTrials.gov (NCT03468361) aimed to assess the diuretic and antihypertensive effect of parsley in hypertensive patients was ultimately withdrawn because the hospitals could not enroll any patients, leaving a critical evidence gap in human research.

Evidence strength: Animal/in vitro evidence is consistent and mechanistically plausible. Human clinical evidence is currently insufficient and inconclusive.

5.2 Antioxidant Activity

One human study demonstrated that apigenin was absorbed systemically by a subject fed a diet high in parsley; this subject was found to have elevated levels of the antioxidant enzymes erythrocyte glutathione reductase and superoxide dismutase.

In one randomized crossover human intervention study, a basic diet was supplemented with chopped parsley providing approximately 51 mg of apigenin equivalent each day (mainly as apigenin-7-apioside, or apiin) for one week, and the excretion of apigenin was measured. This study confirmed the bioavailability of apigenin from dietary parsley in humans. The bioavailability of apigenin from parsley has been confirmed in human studies, indicating its potential biological effects.

Evidence strength: Bioavailability of key antioxidant compounds from dietary parsley is established in humans. Clinical benefits of parsley-derived antioxidants have not been studied in sufficiently powered human trials.

5.3 Cardiovascular Health — Antiplatelet and Antithrombotic Effects

Parsley has been shown to have several health-promoting activities, such as antithrombotic, antihypertensive, and hypolipidemic properties; the multiple studies conducted in animal models so far suggest this species is a potential source of cardioprotective agents.

In vitro, an infusion from the aerial parts of parsley inhibited thrombin- and ADP-induced platelet aggregation (IC50 values of 6.4 and 6.7 mg/mL, respectively). Interdisciplinary in vitro studies showed the antiplatelet activity of a parsley flat-leaf variety leaf decoction and two of its flavonoids — apigenin and cosmosiin (apigenin-7-O-glucoside) — which had IC50 values of 1.8, 0.04, and 0.2 mg/mL, respectively, in an ADP-induced aggregation assay. These extracts and flavonoids showed no anticoagulant effects, having not prolonged clotting time in PT and aPTT assays. The antiplatelet activity of parsley was later confirmed by in vivo studies.

The flavonoids apigenin and cosmosiin extracted from parsley showed antiplatelet activity in vitro and in rodents.

Evidence strength: In vitro and rodent data are relatively consistent. No human clinical trials on parsley's antiplatelet or antithrombotic effects have been published as of available literature.

5.4 Antimicrobial Activity

Antimicrobial activities of parsley extracts have been explored, with results revealing a good bioactivity against specific tested pathogens such as bacteria and fungi. Parsley contains several antimicrobial furocoumarins: psoralen, 8-methoxypsoralen, 5-methoxypsoralen, oxypeucedanin, and isopimpinellin.

Evidence strength: Primarily in vitro. No human clinical trials have examined parsley as a direct antimicrobial agent.

5.5 Renal Health and Kidney Protection

A systematic review identified relevant studies on parsley's biochemical properties — including flavonoids, phenolic acids, terpenoids, and essential oils — which contribute to antioxidant, anti-inflammatory, diuretic, and nephroprotective effects. Animal studies demonstrated reductions in oxidative stress, improvements in metabolic biomarkers, and enhanced renal function, while limited human studies revealed only modest improvements in urinary composition and renal health markers.

This body of evidence highlights parsley's therapeutic potential as a natural agent for renal health and underscores the need for robust clinical trials, long-term safety evaluations, and standardized methodologies to validate its clinical significance.

Evidence strength: Predominantly animal and preclinical. Human evidence is extremely limited and mostly indirect.

5.6 Blood Glucose Regulation / Hypoglycemic Effects

Research by Koyuturk et al. (2010) showed that parsley extract lowered blood glucose, serum urea, and creatinine levels, and reduced histopathological damage in kidneys of diabetic rats, with effects comparable to glibornuride. Parsley's anti-inflammatory properties have been suggested to help mitigate inflammation, further supporting insulin function and glucose metabolism, underscoring its potential as a complementary treatment for diabetes.

Evidence strength: Primarily animal models. No adequately powered human clinical trials specifically investigating parsley for glycemic control have been published.

5.7 Hepatoprotective Effects

Parsley extract administration has been shown in animal studies to reverse biochemical markers of liver injury and preserve liver histology, indicating hepatoprotection likely linked to antioxidative action. Apigenin, abundantly present in parsley, inhibits cancer growth and proliferation, promotes apoptosis, induces cell cycle arrest, and disrupts cancer cells' mitochondrial membrane potential in vitro and in vivo; it has attracted considerable attention as a health-beneficial agent, primarily owing to its minimal intrinsic toxicity.

Evidence strength: Animal studies only. No controlled human trials on parsley's hepatoprotective effects have been reported.

5.8 Anticancer / Chemopreventive Properties

Apigenin, a naturally occurring plant flavone abundantly present in parsley, is recognized as a bioactive flavonoid possessing anti-inflammatory, antioxidant, and anticancer properties. Epidemiological studies suggest that a diet rich in flavones is related to a decreased risk of certain cancers, particularly cancers of the breast, digestive tract, skin, prostate, and certain hematological malignancies.

Human clinical trials examining the effect of supplementation of apigenin on disease prevention have not been conducted, although there is considerable potential for apigenin to be developed as a cancer chemopreventive agent.

Apigenin reportedly has protective effects against a wide variety of cancers, though these findings largely derive from preclinical work. Research has suggested that apigenin could enhance the therapeutic efficacy of sorafenib against liver cancer, but further research is imperative to gain more in-depth mechanistic insights.

Evidence strength: Mechanistically promising in vitro and animal data. No human clinical trials specifically using parsley or apigenin supplements for cancer prevention or treatment have been completed.

5.9 Uric Acid and Gout-Related Effects

Modern in vitro and in vivo studies reveal hypouricemic effects among the pharmacological activities attributed to various parsley preparations. Traditional use for gout and rheumatism, attributed in part to parsley's diuretic action, is consistent with this finding, though human trial data are absent.

Evidence strength: Preclinical only.

6. Dosage Forms and Reported Dosages

Parsley is available in multiple preparations. The following dosages are drawn from published or referenced sources:

• Dried leaf or root (infusion/tea): The usual dose of parsley leaf or root is 6 grams of dried plant per day, consumed in three doses of 2 g each, steeped in 150 ml of water.
• Liquid extract (leaf or root): The extract of parsley leaf and root is made at a ratio of 1 g of plant to 1 ml of liquid and is used at a dose of 2 ml three times daily.
• Seed tea: Tea made from parsley seeds is used at a lower dosage of 2–3 g per day, using 1 g of seed per cup of tea.
• Essential oil (steam-distilled): Parsley seed oil and herb oil are obtained from the above-ground plant parts by steam distillation. Concentrated essential oil preparations carry significant toxicity risk (see Safety section below) and are not appropriate for general consumption.
• Fresh herb (dietary): Consumed as a food in typical culinary quantities. In one intervention study, dietary supplementation with chopped parsley provided approximately 51 mg of apigenin equivalent per day.

It should be noted that standardized dosages for parsley as a medicinal supplement have not been established by major regulatory agencies, and significant variability exists in the composition of commercial preparations.

7. Body Systems and Health Areas

Parsley has been used as a carminative, gastro-tonic, diuretic, antiseptic of the urinary tract, anti-urolithiatic, antidote, and anti-inflammatory agent, and for the treatment of amenorrhea, dysmenorrhea, gastrointestinal disorder, hypertension, cardiac disease, urinary disease, otitis, sniffle (rhinitis), diabetes, and various dermal conditions in traditional and folklore medicines.

A wide range of pharmacological activities — including antioxidant, hepatoprotective, brain-protective, anti-diabetic, analgesic, spasmolytic, immunosuppressant, anti-platelet, gastroprotective, cytoprotective, laxative, estrogenic, diuretic, hypotensive, antibacterial, and antifungal activities — have been attributed to this plant in modern preclinical medicine.

The principal body systems with which parsley is associated include:

• Urinary/Renal System: Diuresis, urinary tract antisepsis, kidney stone prevention, and management of urinary infections — the most historically documented and preclinically studied area.
• Cardiovascular System: Antithrombotic (antiplatelet), antihypertensive, and hypolipidemic activities, primarily studied in vitro and in animal models.
• Gastrointestinal System: Carminative, gastro-tonic, and laxative effects; traditional use for dysentery, gallstones, flatulence, and colic.
• Endocrine/Metabolic: Hypoglycemic and hypouricemic effects in animal models; traditional use in diabetes management.
• Reproductive System: Traditional use as an emmenagogue (to stimulate menstruation) and, at high doses, as an abortifacient.
• Liver/Hepatic System: Hepatoprotective effects demonstrated in animal models.
• Immune and Oncological: In vitro evidence for anticancer properties of apigenin; no human trials completed.

8. Safety Considerations and Interactions

General Safety at Culinary Doses

Parsley has GRAS (Generally Recognized As Safe) status when used as food. Consumption as a food ingredient in typical culinary amounts is considered safe for most adults.

Toxicity of High Doses and Essential Oil

Adverse effects from ingestion of parsley oil include headache, giddiness, loss of balance, convulsions, and renal damage. The parsley extract chemical constituents apiol and myristicin are associated with potential toxicities; the essential (pure) oil is toxic, with various case reports of mortality cited in the literature.

Results from animal studies indicate that the leaf ethanol extract of Petroselinum crispum was mildly hepatotoxic and nephrotoxic at continued oral doses equal to or more than 1,000 mg/kg, but demonstrated no obvious toxicity when used at lower doses.

Pregnancy and Lactation

While no major toxicities have been reported from ordinary food use, parsley should not be taken during pregnancy because of possible uterotonic effects. Amounts greater than those used in foods should be avoided, as safety and efficacy are unproven; emmenagogue and abortifacient effects may occur with higher doses. Ingestion of parsley should be discouraged in pregnancy, lactating mothers, and in individuals on opioids, lithium salts, diuretics, and warfarin therapy due to potential drug-herb interactions.

Photosensitivity

Parsley contains psoralen and other related furocoumarin compounds — including ficusin, bergapten, majudin, and heraclin — that can induce photosensitivity. The psoralen-related compounds found in parsley have been linked to photodermatitis reactions among parsley cutters, particularly with occupational skin exposure combined with sunlight.

Interactions with Warfarin (Anticoagulants)

Warfarin is taken to thin the blood and slow blood clotting. Large amounts of parsley leaf might increase blood clotting; taking parsley along with warfarin might decrease how well warfarin works to thin the blood. This interaction is attributed to parsley's high vitamin K content, which can antagonize warfarin's anticoagulant mechanism.

Interaction with Diuretics

Combining parsley with pharmaceutical diuretics can lead to excessive fluid loss, dehydration, and electrolyte imbalances (e.g., low potassium).

Interaction with Lithium

Parsley's diuretic effect might decrease the body's ability to excrete lithium, potentially leading to toxic levels of the drug.

Interaction with CYP1A Substrates

Consuming apiole, a constituent of parsley, in conjunction with pharmaceuticals metabolized by the CYP1A subfamily may result in herb-drug interactions, as apiole has been identified as a mixed-type inhibitor of CYP1A1 and CYP1A2.

Interaction with Sirolimus

Parsley may increase the serum concentration of sirolimus.

Allergy

Some people are allergic to parsley; aspirin might increase sensitivity to parsley, making allergic reactions worse. Cross-reactivity within the Apiaceae family (e.g., with celery, carrot, and fennel) is a recognized phenomenon.

Kidney Stone Risk

Parsley is high in oxalates, a natural compound that can bind with calcium and contribute to the formation of kidney stones in susceptible individuals; those with a history of kidney problems should limit their intake.

References

• Arsić et al. (2021). A review of botanical characteristics, chemical composition, pharmacological activity and use of parsley. Archives of Pharmacy.
• Farzaei MH et al. (2013). Parsley: a review of ethnopharmacology, phytochemistry and biological activities. Journal of Traditional Chinese Medicine. ScienceDirect.
• Balaha M et al. (2024). Renal health benefits and therapeutic effects of parsley (Petroselinum crispum): a review. Frontiers in Medicine. PMC.
• Amaro MI et al. (2020). Bioactive Properties and Phenolic Compound Profiles of Turnip-Rooted, Plain-Leafed and Curly-Leafed Parsley Cultivars. PMC.
• Leite PM et al. (2024). What Is New about Parsley, a Potential Source of Cardioprotective Therapeutic Substances? Nutraceuticals. MDPI.
• Aslam MN et al. (2014). Critique of medicinal conspicuousness of parsley (Petroselinum crispum): a culinary herb of Mediterranean region. PubMed.
• Kreydiyyeh SI & Usta J. (2002). Diuretic effect and mechanism of action of parsley. Journal of Ethnopharmacology. ScienceDirect.
• Salehi B et al. (2019). The Therapeutic Potential of Apigenin. PMC/NIH.
• Shukla S & Gupta S. (2010). Apigenin: A Promising Molecule for Cancer Prevention. PMC.
• Dymarska E et al. (2019). A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota. PMC.
• Menezes AMSF et al. (2021). Pharmacological and Therapeutic Potential of Myristicin: A Literature Review. PMC.
• Apiole, an important constituent of parsley, is a mixed-type inhibitor of the CYP1A subfamily. Chemico-Biological Interactions. ScienceDirect (2024).
• Igile GO et al. (2013). Biochemical and haematological assessment of toxic effects of the leaf ethanol extract of Petroselinum crispum in rats. PMC.
• Botez S et al. (2018). Botanical Therapeutics: Phytochemical Screening and Biological Assessment of Chamomile, Parsley and Celery Extracts against A375 Human Melanoma and Dendritic Cells. PMC.
• Drugs.com. Parsley Uses, Benefits & Dosage — Natural Products Database (Pharmacist/Clinician Reference).
• EBSCO Research Starters. Parsley's Therapeutic Uses. Health and Medicine.
• ClinicalTrials.gov. NCT03468361: Diuretic Effect Evaluation of Petroselinum crispum (Parsley) in Hypertensive Patients.
• ScienceDirect Topics. Parsley — Overview.
• Therapeutic relevance of Petroselinum crispum: Phytochemical insights, pharmacological evidence, formulation approaches and clinical perspectives. Food Science and Human Wellness. ScienceDirect (2026).
• Abaza MA et al. (2024). Apigenin enhances sorafenib anti-tumour efficacy in hepatocellular carcinoma. PMC.
• Apigenin as an emerging hepatoprotective agent: current status and future perspectives. PMC (2025).